Effect of Phytalgic in Osteoarthritis (OA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00666523
Recruitment Status : Completed
First Posted : April 25, 2008
Last Update Posted : April 25, 2008
laboratoire Phythea, France
Information provided by:
Université Victor Segalen Bordeaux 2

Brief Summary:
The objective of the study is to test the effects of a herbal supplement, Phytalgic, on the symptoms of osteoarthritis of the knee or hip, in patients with OA using NSAIDs or analgesics on a regular basis.

Condition or disease Intervention/treatment
Osteoarthritis Dietary Supplement: phytalgic Dietary Supplement: placebo

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 81 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomized Double-Blind Study of Food Supplement Phytalgic on Symptoms of Osteoarthritis
Study Start Date : January 2007
Primary Completion Date : January 2008
Study Completion Date : April 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Osteoarthritis
U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1 Dietary Supplement: phytalgic
Placebo Comparator: 2 Dietary Supplement: placebo

Primary Outcome Measures :
  1. use of NSAIDs or analgesics [ Time Frame: 3 months ]

Secondary Outcome Measures :
  1. WOMAC function scale [ Time Frame: 3 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • knee or hip osteoarthritis
  • regular NSAIDs/analgesic treatment
  • signed inform consent

Exclusion Criteria:

  • incapacity to understand study
  • irregular NSAID treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00666523

Dept of Pharmacology, U-Bordeaux2, BP36
Bordeaux, France, 33076
Sponsors and Collaborators
Université Victor Segalen Bordeaux 2
laboratoire Phythea, France
Study Director: Nicholas Moore, MD, PhD University of Bordeaux

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Alain Jacquet, Dept of pharmacology, CHU Bordeaux Identifier: NCT00666523     History of Changes
Other Study ID Numbers: PhytalgicOA
First Posted: April 25, 2008    Key Record Dates
Last Update Posted: April 25, 2008
Last Verified: April 2008

Keywords provided by Université Victor Segalen Bordeaux 2:
osteoarthritis, knee or hip

Additional relevant MeSH terms:
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases